Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105749 · ClinicalTrials.gov registry record · NA
Biennial CEM in Women With a Personal History of Breast Cancer
A NA study of Breast Cancer and Neoplasms, sponsored by Wendie Berg.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 6
- Study locations
NCT06105749: Recruiting NA study of Breast Cancer and Neoplasms, sponsored by Wendie Berg.
NCT06105749 is a NA study of Breast Cancer and Neoplasms that is actively recruiting participants, run by Wendie Berg. The registered enrollment target is 1,500 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (46% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06105749, a NA study of Breast Cancer and Neoplasms, is actively recruiting participants, sponsored by Wendie Berg.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
Primary Outcome
CEM cancer detection rate for first observer vs usual care (annual DBT)
Conditions Studied
Interventions
- DEVICE contrast-enhanced mammography
Study Locations (6)
Pennsylvania
- UPMC Magee-Womens Imaging - Bethel Park - Bethel Park
- UPMC Magee at the Lemieux Sports Complex - Cranberry Township
- Magee Womancare Monroeville - Monroeville
- Magee-Womens Hospital - Pittsburgh
- Hillman Cancer Center at Shadyside - Pittsburgh
- UPMC West Mifflin Outpatient Center - West Mifflin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2031-04 |
| Phase | NA |
What NCT06105749 shows while recruiting
NCT06105749 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (46% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which contrast-enhanced mammography is the first listed.
NCT06105749 lists 6 locations in 1 state (Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT06105749 about?
NCT06105749 is a clinical study titled "Biennial CEM in Women With a Personal History of Breast Cancer". This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
What is the current status of trial NCT06105749?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2023-11-08. Estimated completion is 2031-04.
What conditions does trial NCT06105749 study?
This clinical trial studies the following conditions: Breast Cancer, Neoplasms, Breast Neoplasms, Breast Cancer Female.
What interventions are being tested in trial NCT06105749?
The interventions under investigation include: contrast-enhanced mammography (DEVICE).
Who is sponsoring clinical trial NCT06105749?
This trial is sponsored by Wendie Berg, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06105749 being conducted?
This trial has 6 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06105749's enrollment target sits among peer trials
1,500 82nd of 1224 higher than 1,141 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI